Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update
Rigel Pharmaceuticals (Nasdaq: RIGL) has scheduled its first quarter 2025 financial results announcement and business update for Tuesday, May 6, 2025, after market close. The company will host a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
Investors can join the call through two options:
- Phone: 877-407-3088 (domestic) or 201-389-0927 (international)
- Webcast: Available through the Investor Relations section at www.rigel.com
Rigel, founded in 1996 and based in South San Francisco, is a biotechnology company focused on developing therapies for hematologic disorders and cancer. The webcast will be archived and accessible for replay through the company website for 90 days following the call.
Rigel Pharmaceuticals (Nasdaq: RIGL) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 e l'aggiornamento aziendale per marted矛 6 maggio 2025, dopo la chiusura dei mercati. La societ脿 terr脿 una conference call e una trasmissione in diretta alle 16:30 ora Eastern (13:30 ora Pacific).
Gli investitori possono partecipare alla chiamata tramite due modalit脿:
- Telefono: 877-407-3088 (nazionale) o 201-389-0927 (internazionale)
- Webcast: disponibile nella sezione Investor Relations su www.rigel.com
Rigel, fondata nel 1996 e con sede a South San Francisco, 猫 una azienda biotecnologica specializzata nello sviluppo di terapie per disturbi ematologici e tumori. La registrazione della trasmissione sar脿 archiviata e disponibile per la visione in replica sul sito aziendale per 90 giorni dopo la chiamata.
Rigel Pharmaceuticals (Nasdaq: RIGL) ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 y una actualizaci贸n empresarial para el martes 6 de mayo de 2025, despu茅s del cierre del mercado. La compa帽铆a realizar谩 una conferencia telef贸nica en vivo y una transmisi贸n web a las 4:30 p.m. hora del Este (1:30 p.m. hora del Pac铆fico).
Los inversores pueden unirse a la llamada a trav茅s de dos opciones:
- Tel茅fono: 877-407-3088 (nacional) o 201-389-0927 (internacional)
- Webcast: Disponible en la secci贸n de Relaciones con Inversores en www.rigel.com
Rigel, fundada en 1996 y con sede en South San Francisco, es una compa帽铆a biotecnol贸gica enfocada en desarrollar terapias para trastornos hematol贸gicos y c谩ncer. La transmisi贸n quedar谩 archivada y disponible para reproducci贸n en el sitio web de la compa帽铆a durante 90 d铆as despu茅s de la llamada.
Rigel Pharmaceuticals (雮橃姢雼�: RIGL)電� 2025雲� 1攵勱赴 鞛 鞁れ爜 氚滍憸 氚� 靷梾 鞐呺嵃鞚错姼毳� 2025雲� 5鞗� 6鞚� 頇旍殧鞚� 鞛� 毵堦皭 頉勳棎 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 須岇偓電� 霃欕秬 鞁滉皠 鞓ろ泟 4鞁� 30攵�(韮滍弶鞏� 鞁滉皠 鞓ろ泟 1鞁� 30攵�)鞐� 霛检澊敫� 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 臧滌禍頃╇媹雼�.
韴瀽鞛愲摛鞚� 雼れ潓 霊� 臧�歆� 氚╇矔鞙茧 韱淀檾鞐� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟:
- 鞝勴檾: 甑偞 877-407-3088 霕愲姅 甑牅 201-389-0927
- 鞗轨簮鞀ろ姼: www.rigel.com鞚� 韴瀽鞛� 甏�瓿� 靹轨厴鞐愳劀 鞚挫毄 臧�電�
Rigel鞚� 1996雲勳棎 靹る霅橃柎 South San Francisco鞐� 氤胳偓毳� 霊� 靸濍獏瓿淀暀 旮办梾鞙茧, 順堨暋 歆堩櫂 氚� 鞎� 旃橂鞝� 臧滊皽鞐� 欤茧牓頃橁碃 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼電� 旖� 膦呺 頉� 90鞚� 霃欖晥 須岇偓 鞗轨偓鞚错姼鞐愳劀 雼れ嫓氤搓赴搿� 鞝滉车霅╇媹雼�.
Rigel Pharmaceuticals (Nasdaq : RIGL) a programm茅 l'annonce de ses r茅sultats financiers du premier trimestre 2025 et une mise 脿 jour commerciale pour le mardi 6 mai 2025, apr猫s la cl么ture des march茅s. La soci茅t茅 organisera une conf茅rence t茅l茅phonique en direct et une diffusion en webcast 脿 16h30 heure de l'Est (13h30 heure du Pacifique).
Les investisseurs peuvent rejoindre l'appel via deux options :
- T茅l茅phone : 877-407-3088 (domestique) ou 201-389-0927 (international)
- Webcast : disponible dans la section Relations Investisseurs sur www.rigel.com
Rigel, fond茅e en 1996 et bas茅e 脿 South San Francisco, est une soci茅t茅 de biotechnologie sp茅cialis茅e dans le d茅veloppement de th茅rapies pour les troubles h茅matologiques et le cancer. Le webcast sera archiv茅 et accessible en replay sur le site de la soci茅t茅 pendant 90 jours apr猫s l'appel.
Rigel Pharmaceuticals (Nasdaq: RIGL) hat die Bekanntgabe der Finanzergebnisse f眉r das erste Quartal 2025 und ein Gesch盲ftsupdate f眉r Dienstag, den 6. Mai 2025, nach B枚rsenschluss geplant. Das Unternehmen wird eine Live-Konferenzschaltung und einen Webcast um 16:30 Uhr Eastern Time (13:30 Uhr Pacific Time) veranstalten.
Investoren k枚nnen 眉ber zwei Optionen an dem Anruf teilnehmen:
- Telefon: 877-407-3088 (national) oder 201-389-0927 (international)
- Webcast: Verf眉gbar im Bereich Investor Relations auf www.rigel.com
Rigel, gegr眉ndet 1996 mit Sitz in South San Francisco, ist ein Biotechnologieunternehmen, das sich auf die Entwicklung von Therapien f眉r h盲matologische Erkrankungen und Krebs spezialisiert hat. Der Webcast wird archiviert und f眉r 90 Tage nach dem Anruf auf der Unternehmenswebsite zum Nachsehen bereitgestellt.
- Maintains regular investor communication through scheduled earnings call and webcast
- Provides multiple access methods for investors (phone and webcast)
- 90-day replay availability of the webcast shows transparency
- None.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international).听The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at .听The webcast will be archived and available for replay for 90 days after the call via the Rigel website.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media: 听
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
[email protected]
Media:
David Rosen
Argot Partners
Phone: 646.461.6387
贰尘补颈濒:鈥�[email protected]听 听 听
听
View original content to download multimedia:
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
When will Rigel (RIGL) report Q1 2025 earnings?
How can investors join Rigel's (RIGL) Q1 2025 earnings call?
Where can I find the replay of Rigel's (RIGL) Q1 2025 earnings webcast?
What is Rigel's (RIGL) main business focus?
How long has Rigel (RIGL) been in business?
